These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies]. Kusunoki S Rinsho Shinkeigaku; 1999 Jan; 39(1):93-5. PubMed ID: 10377820 [TBL] [Abstract][Full Text] [Related]
43. Comparison of immunoblotting and ELISA for detection of anti-ganglioside antibodies in children with Guillain-Barre syndrome. Bonyadi MR; Barzegar M; Badalzadeh R; Hashemilar M Iran J Immunol; 2010 Jun; 7(2):117-23. PubMed ID: 20574125 [TBL] [Abstract][Full Text] [Related]
44. Anti-ganglioside antibodies in patients with Guillain Barré syndrome and other neurological disorders. Vaishnavi C; Behura C; Prabhakar S; Sharma A; Kharbanda P Indian J Med Microbiol; 2013; 31(2):177-9. PubMed ID: 23867676 [TBL] [Abstract][Full Text] [Related]
45. Antiganglioside antibody frequency in routine clinical care settings. Giesche N; Böhm-Gonzalez ST; Kleiser B; Kowarik MC; Dubois E; Stransky E; Armbruster M; Grimm A; Marquetand J Eur J Neurol; 2024 Jul; 31(7):e16290. PubMed ID: 38556758 [TBL] [Abstract][Full Text] [Related]
46. Anti-ganglioside antibodies profile in Guillain-Barré syndrome: Correlation with clinical features, electrophysiological pattern, and outcome. Naik GS; Meena AK; Reddy BAK; Mridula RK; Jabeen SA; Borgohain R Neurol India; 2017; 65(5):1001-1005. PubMed ID: 28879885 [TBL] [Abstract][Full Text] [Related]
47. Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome. Yako K; Kusunoki S; Kanazawa I J Neurol Sci; 1999 Oct; 168(2):85-9. PubMed ID: 10526188 [TBL] [Abstract][Full Text] [Related]
48. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome. Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484 [TBL] [Abstract][Full Text] [Related]
50. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome. Yuki N; Susuki K; Hirata K Neurology; 2000 May; 54(9):1851-3. PubMed ID: 10802797 [TBL] [Abstract][Full Text] [Related]
51. [Antiganglioside antibodies: when, which and for what]. Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721 [TBL] [Abstract][Full Text] [Related]
52. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes]. Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515 [TBL] [Abstract][Full Text] [Related]
53. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome. Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757 [TBL] [Abstract][Full Text] [Related]
54. Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions. Shahrizaila N; Yuki N Expert Rev Neurother; 2011 Sep; 11(9):1305-13. PubMed ID: 21864076 [TBL] [Abstract][Full Text] [Related]
55. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies]. Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060 [TBL] [Abstract][Full Text] [Related]
56. [Anti-GD1b IgG positive case of overlapping Ficher's and Guillain-Barré syndromes]. Caudie C; Schandelong A; Rapoport F; Vial C Ann Biol Clin (Paris); 2004; 62(5):591-4. PubMed ID: 15355812 [TBL] [Abstract][Full Text] [Related]
57. Antibodies to ganglioside complexes in Guillain-Barré syndrome: clinical correlates, fine specificity and complement activation. Notturno F; Luciani M; Caporale CM; Ciarelli A; Uncini A Int J Immunopathol Pharmacol; 2009; 22(2):437-45. PubMed ID: 19505396 [TBL] [Abstract][Full Text] [Related]
58. Complete recovery of an aged patient with Guillain-Barré syndrome associated with multiple IgM anti-ganglioside antibodies. Furiya Y; Hirano M; Kusunoki S; Ueda M; Sugie K; Nishiwaki T; Ueno S Muscle Nerve; 2008 Dec; 38(6):1630-3. PubMed ID: 19016534 [TBL] [Abstract][Full Text] [Related]
59. [Antiganglioside antibodies--their pathophysiological effects on Guillain-Barré syndrome and variants]. Kaida K; Kusunoki S Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(1):29-39. PubMed ID: 21372511 [TBL] [Abstract][Full Text] [Related]